The ACR/ARHP Member News

Comparing the triad of DMARDs to the biologic therapy, the study demonstrated “similar clinical and radiologic results,” says Dr. O’Dell. In addition, he says the use of DMARDs could “save a half million dollars over a patient’s life time.”

Dr. O’Dell is chief of the University of Nebraska Medical Center Division of Rheumatology and Immunology and chief of rheumatology at the Omaha (Neb.) VA Medical Center.

Ann-Marie Lindstrom is an independent writer and editor based in the Tucson, Ariz., area.

Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythematosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…

CHICAGO—Because the epigenome has been implicated in a variety of rheumatic conditions, a Basic Research Conference was convened on Epigenetics in Immune-Mediated Disease in conjunction with the 2018 ACR/ARHP Annual Meeting. Melanie Ehrlich, PhD, professor of human genetics and genomics at Tulane University School of Medicine, New Orleans, opened the conference. She has a long…

CHICAGO—With the approval of the Jak inhibitors (i.e., jakinibs) tofacitinib and ruxolitinib—and others being investigated—rheumatologists need to arm themselves with an understanding of these drugs so they can think critically when evaluating them and deciding how to use them, said John O’Shea, MD, chief of the Molecular Immunology and Inflammation Branch of and scientific director…

Marian Hannan Celebrated after 10 Years as AC&R Editor-in-Chief By Kelly April Tyrrell This summer, the 10-year tenure of Marian Hannan, MPH, DSc, as editor in chief of Arthritis Care & Research (AC&R), has come to an end. Kelli Allen, PhD, assumed the post on July 1. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUE“Marian has done a…

A 52-Year-Old Lupus Paper Remains Important Today

The Latest on Epigenetics in Immune-Mediated Disease

The ACR’s State-of-the-Art Clinical Symposium: Experts Discuss Jakinibs, Osteoarthritis, Membranous Lupus Nephritis

Summer 2021’s Awards, Appointments & Announcements in Rheumatology

Related Articles